Season 1 Episode 08 UE LifeSciences

FTEs: 26
iBreastExams Performed: 450,000
Revenues: $3M (cumulative 2018 – 2020)
Grant Awards: $1.7M
Capital Raised: $4.85M
Â
FTEs: 26
iBreastExams Performed: 450,000
Revenues: $3M (cumulative 2018 – 2020)
Grant Awards: $1.7M
Capital Raised: $4.85M
Â
OUR MISSION
To make early detection of common cancers in women, inclusive and accessible – with the power of innovation.
OURÂ GOAL
To bring early detection of Breast and Cervical cancers for 10 million women in 5 years, globally.
ABOUT US
UE LifeSciences is a women’s health company focused on preventive oncology. It designs, develops and commercializes medical technology solutions that enable early detection of leading cancers in women.
Watch our TED talksÂ
Awards & Recognitions
Any historical returns, expected returns, or probability projections may not reflect actual future performance. These examples are extreme and rare examples of returns that have been realized. It should not be assumed that these types of results are common or that they should be expected. Investing in private companies offers the opportunity to earn a high return on your investment, but also carries significant risks, including lack of liquidity and potential loss of some or all of your investment. Past performance is no guarantee of future results. Please refer to Risks and Disclaimers to learn more about the risks associated with investing in private companies.